Biological
Shanchol clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 2
- first study started
- 2009
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2012 (4)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
- Phase 3
- 2
- Phase 4
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 8
International Centre for Diarrhoeal Disease Research, Bangladesh (3) · Johns Hopkins Bloomberg School of Public Health (2) · Sanofi Pasteur, a Sanofi Company (2) · International Vaccine Institute (2) · Sachin Desai (1)
Often tested with
Tested in the same studies.
Cholera Vaccines (1)
Studies
Open first, then newest update. How each study uses shanchol is read from its arms, and is right about nine times in ten.
Testing it · 10
- Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje MalawiTerminatedNot applicableJohns Hopkins Bloomberg School of Public HealthNCT02499172Written as Shanchol
- Extended Dose Intervals With Oral Cholera Vaccine in CameroonCompletedPhase 2Johns Hopkins Bloomberg School of Public HealthNCT03719066Written as killed whole cell oral cholera vaccine
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican RepublicCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT02434822Written as Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the PhilippinesCompletedPhase 4Sanofi Pasteur, a Sanofi CompanyNCT01949675Written as Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
- Single Dose Oral Cholera Vaccine Study in Dhaka, BangladeshCompletedPhase 3International Centre for Diarrhoeal Disease Research, BangladeshNCT02027207Written as Shanchol
- Introduction of Cholera Vaccine in BangladeshCompletedNot applicableInternational Centre for Diarrhoeal Disease Research, BangladeshNCT01339845Written as ShanChol
- Field Application of Shanchol in Adults in BangladeshCompletedPhase 2International Centre for Diarrhoeal Disease Research, BangladeshNCT01762930Written as Shanchol
- Safety and Immunogenicity of a Killed Oral Cholera Vaccine in InfantsStatus unknownPhase 2International Vaccine InstituteNCT00548054Written as Bivalent killed oral cholera vaccine
- A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and ChildrenCompletedPhase 4International Vaccine InstituteNCT00760825Written as killed bivalent (O1 and O139)whole cell oral cholera vaccine
- Evaluation of a Boosting Regimen With Oral Cholera VaccineCompletedPhase 4Sachin DesaiNCT01579448Written as Shanchol™, oral cholera vaccine
As the comparator · 5 — what is tested is compared with shanchol
- Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™CompletedPhase 3International Vaccine InstituteNCT04760236Written as Shanchol™
- PXVX0200 (CVD103-HgR) vs Shanchol in MaliCompletedPhase 2University of Maryland, BaltimoreNCT02145377Written as Shanchol
- Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera VaccineCompletedPhase 1/2International Centre for Diarrhoeal Disease Research, BangladeshNCT02823899Written as Shanchol
- Safety and Immunogenicity of Locally Manufactured Oral Cholera VaccineCompletedPhase 2International Centre for Diarrhoeal Disease Research, BangladeshNCT02742558Written as Shanchol
- To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and ChildrenCompletedPhase 3EuBiologics Co.,LtdNCT02164110Written as Shanchol